The molecule, mitogen-activated protein kinase, or MAP kinase, is five to 20 percent more prevalent in women with breast cancer than in those without the affliction.
What the SUNY team found was that some breast-cancer cells contain elevated levels of enzymes known as mitogen-activated protein kinases.
Research and Markets: The MAPK Signaling Pathway in Oncology Drug Pipeline Update 2013 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bcs7gl/the_mapk) has announced the addition of the "The MAPK Signaling Pathway in Oncology Drug Pipeline Update 2013" report to their offering. The mitogen-activated protein kinase (MAPK) cascade is a highly conserved module that is involved in various cellular functions, including cell proliferation ...
June 14, 2013 - Business Wire